Bio-Pharma Logistics Market to Grow with a CAGR of 7.16% through 2028
Globalization of
pharmaceutical supply chains is expected to drive the Global Bio-Pharma
Logistics Market growth in the forecast period, 2024-2028.
According
to TechSci Research report, “Bio-Pharma Logistics Market – Global Industry
Size, Share, Trends, Competition Forecast & Opportunities, 2028”,
the Global Bio-Pharma Logistics Market stood at USD 80.36 billion in 2022 and
is anticipated to grow with a CAGR of 7.16% in the forecast period, 2024-2028. diseases
worldwide. One of the primary drivers fueling the growth of the Global
Bio-Pharma Logistics Market is the ever-increasing demand for biopharmaceutical
products. Biopharmaceuticals, including vaccines, monoclonal antibodies, gene
therapies, and other advanced therapeutic modalities, have gained prominence in
recent years due to their effectiveness in treating various diseases. As
biotechnology and pharmaceutical research advances, the pipeline of
biopharmaceutical products continues to expand. This growing portfolio of
biologics and complex medicines necessitates a robust and reliable logistics
network to ensure their timely delivery to patients worldwide.
The
pharmaceutical industry's global footprint has expanded significantly in recent
years, leading to a greater need for sophisticated logistics solutions.
Pharmaceutical manufacturers often source raw materials and components from
multiple countries, engage in cross-border manufacturing, and distribute
products to global markets. This globalization of the pharmaceutical supply
chain has made logistics a complex and vital part of the industry.
The Global
Bio-Pharma Logistics Market is well-equipped to handle the intricacies of
international trade and regulatory requirements. Logistics providers
specializing in biopharma have expertise in navigating customs regulations,
ensuring compliance with international quality standards, and managing the
transportation of pharmaceutical products across diverse geographies. As the
pharmaceutical supply chain continues to become more interconnected, the demand
for these specialized logistics services is expected to rise.
Temperature-controlled
logistics, also known as the cold chain, is a critical driver for the
bio-pharma logistics market. Many biopharmaceutical products, including
vaccines, biologics, and cell therapies, are highly sensitive to temperature
fluctuations. Deviations from specified temperature ranges can compromise the
efficacy, safety, and quality of these products.
Browse over XX
market data Figures spread through XX Pages and an in-depth TOC on
"Global Bio-Pharma Logistics Market.”
The Global
Bio-Pharma Logistics Market is segmented into Type of Operation, Service, Regional Distribution, And Company.
Based
on the Service, Transportation emerged as the dominant segment in the global
market for Global Bio-Pharma Logistics in 2022. Many biopharmaceutical products are highly sensitive to
temperature fluctuations, and maintaining precise temperature control is
essential. Transportation providers are equipped to offer
temperature-controlled solutions, ensuring that these products are kept within
the required temperature range throughout their journey. Transportation
services are pivotal in ensuring compliance with regulatory requirements such
as Good Distribution Practices (GDP). Specialized logistics providers have the
expertise and infrastructure to meet the stringent quality and safety standards
mandated by regulatory agencies like the FDA and EMA. Transportation services
often integrate real-time tracking and monitoring systems, including the use of
IoT devices, data loggers, and GPS technology. These technologies enable
logistics providers to closely monitor the location, condition, and temperature
of shipments, providing transparency and accountability throughout the
transportation process.
Based
on the Type of Operation, Cold Chain emerged as the dominant segment in the
global market for Global Bio-Pharma Logistics Market in 2022. The pharmaceutical industry is
witnessing a surge in the development and demand for biologics. These complex
medicines often require strict temperature control to maintain their integrity.
The cold chain is essential in ensuring that these valuable and often
high-value biopharmaceuticals are transported and stored under the precise
temperature conditions required. As
the pharmaceutical supply chain extends globally, ensuring temperature control
during international shipments is paramount. The cold chain is equipped to
address the challenges of cross-border transportation, customs inspections, and
varying temperature conditions, ensuring that biopharmaceutical products remain
within their required temperature range.
North
America emerged as the dominant player in the Global Bio-Pharma Logistics Market
in 2022, holding the largest market share. The demand for biopharmaceutical products in North America
is substantial, driven by factors such as an aging population, increasing
prevalence of chronic diseases, and a growing emphasis on personalized
medicine. Biologics and other advanced therapies have gained traction in the
region, necessitating efficient and reliable logistics services to ensure these
products are delivered safely and on time to healthcare providers and patients.
North America has a stringent regulatory environment, with regulatory agencies
like the U.S. Food and Drug Administration (FDA) and Health Canada overseeing
the pharmaceutical and biopharmaceutical industries. Compliance with Good
Distribution Practices (GDP) and Good Manufacturing Practices (GMP) is
essential. This regulatory rigor has led to a demand for logistics providers
that can adhere to these stringent quality and safety standards, ensuring that
pharmaceutical products are transported and stored with the highest levels of
integrity.
Major
companies operating in Global Bio-Pharma Logistics Market are:
- Kerry Logistics
- Deutsche Post
- DHL Group
- Kuehne + Nagel
- UPS (Marken)
- DB Schenker
- FedEx
- Nippon Express
- World Courier
- SF Express
Download Free Sample Report
Customers can
also request for 10% free customization on this report
“The
global Bio-Pharma Logistics market is anticipated to experience significant
growth in the coming years. Anticipated factors include the increasing demand
for biopharmaceutical products such as vaccines, gene therapies, and monoclonal
antibodies. These advanced therapies require specialized and efficient
logistics solutions. Moreover, the globalization of pharmaceutical supply
chains and the stringent regulatory environment will continue to fuel demand
for logistics providers that can ensure compliance and maintain product
integrity. Additionally, advancements in temperature-controlled logistics,
technology, and quality assurance will play a pivotal role in meeting the
evolving needs of the pharmaceutical and biotechnology industries.” said Mr.
Karan Chechi, Research Director with TechSci Research, a research-based
management consulting firm.
“Bio-Pharma
Logistics Market - Global Industry Size, Share, Trends, Opportunity, and
Forecast, 2018-2028 Segmented By Service (Transportation, Warehousing and
Distribution, Value Added Services), By Type of Operation (Cold Chain, Non-cold
Chain) Region and Competition”, has evaluated the future growth
potential of Global Clinical Microbiology Market and provides statistics &
information on market size, structure and future market growth. The report
intends to provide cutting-edge market intelligence and help decision makers
take sound investment decisions. Besides, the report also identifies and
analyzes the emerging trends along with essential drivers, challenges, and
opportunities in Global Clinical Microbiology Market.
Contact
TechSci
Research LLC
420
Lexington Avenue, Suite 300,
New York,
United States- 10170
Tel: +1-332-258-6602
Email: [email protected]
Website: www.techsciresearch.com